What CMOs Must Know About How Patient Engagement Supports the Entire Biotech

This session recorded at CMO Summit 2022 gives CMOs an update on current views on patient-centric medicine development, what it really means and the benefits for both the patient and trial. More specifically:

• Achieving timely recruitment by better selecting sites and writing good protocols
• Working with patient advocacy groups to integrate patient voice in trial design and drive better enrollment
• Achieving enrollment when there is so much competition for patients

Speakers:

• Jodie Gillon, MPH, SVP Corporate Affairs & Patient Advocacy, Peptilogics
• Barry Ticho, MD, PhD, CMO, Stoke Therapeutics
• Rolf Benirschke, Patient Advocate & Former NFL Player, Legacy Health Strategies
• Roger Waltzman, MD, MBA, CMO, Molecular Templates